Literature DB >> 21110317

Genetic proof for the transient nature of the Th17 phenotype.

Florian C Kurschus1, Andrew L Croxford, André P Heinen, Simone Wörtge, Daniele Ielo, Ari Waisman.   

Abstract

IL-17-producing CD4(+) T cells (Th17) have been classified as a new T helper cell subset. Using an IL-17 fate mapping mouse strain, which genetically fixes the memory of IL-17 expression, we demonstrate that IL-17A/F-expressing T helper cells generated either in vitro or in vivo are not a stable T-cell subset. Upon adoptive transfer of IL-17F-reporter-positive Th17 cells to RAG-deficient or WT animals, encephalitogenic Th17 cells partially lose IL-17 expression and upregulate IFN-γ. Additionally, we show that Th1 cells can convert in vivo to IL-17A/IFN-γ-coexpressing cells in the mesenteric lymph nodes (mLN). Our data classify IL-17A and IL-17F as cytokines produced transiently in response to the local microenvironment, thus showing that IL-17 expression does not define an end-stage T helper cell subset.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21110317     DOI: 10.1002/eji.201040755

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  56 in total

Review 1.  Interleukin-23 and T helper 17-type responses in intestinal inflammation: from cytokines to T-cell plasticity.

Authors:  Peter J Morrison; Sarah J Ballantyne; Marika C Kullberg
Journal:  Immunology       Date:  2011-06-02       Impact factor: 7.397

Review 2.  Immune Mechanisms in Arterial Hypertension.

Authors:  Ulrich Wenzel; Jan Eric Turner; Christian Krebs; Christian Kurts; David G Harrison; Heimo Ehmke
Journal:  J Am Soc Nephrol       Date:  2015-08-28       Impact factor: 10.121

3.  Expression of IL-17F is associated with non-pathogenic Th17 cells.

Authors:  Florian Wanke; Yilang Tang; Konrad Gronke; Sabrina Klebow; Sonja Moos; Judith Hauptmann; Arthi Shanmugavadivu; Tommy Regen; Ilgiz A Mufazalov; Lauren A Gabriel; Sonja Reißig; Andreas Diefenbach; Florian C Kurschus; Ari Waisman
Journal:  J Mol Med (Berl)       Date:  2018-06-29       Impact factor: 4.599

4.  Transfer of myelin-reactive th17 cells impairs endogenous remyelination in the central nervous system of cuprizone-fed mice.

Authors:  Emily G Baxi; Joseph DeBruin; Dominique M Tosi; Inna V Grishkan; Matthew D Smith; Leslie A Kirby; Hayley J Strasburger; Amanda N Fairchild; Peter A Calabresi; Anne R Gocke
Journal:  J Neurosci       Date:  2015-06-03       Impact factor: 6.167

5.  Vaccine-induced th17 cells are maintained long-term postvaccination as a distinct and phenotypically stable memory subset.

Authors:  Thomas Lindenstrøm; Joshua Woodworth; Jes Dietrich; Claus Aagaard; Peter Andersen; Else Marie Agger
Journal:  Infect Immun       Date:  2012-07-30       Impact factor: 3.441

6.  T-bet promotes the accumulation of encephalitogenic Th17 cells in the CNS.

Authors:  Heather M Grifka-Walk; Benjamin M Segal
Journal:  J Neuroimmunol       Date:  2016-05-24       Impact factor: 3.478

7.  CNS-Specific Synthesis of Interleukin 23 Induces a Progressive Cerebellar Ataxia and the Accumulation of Both T and B Cells in the Brain: Characterization of a Novel Transgenic Mouse Model.

Authors:  Louisa Nitsch; Julian Zimmermann; Marius Krauthausen; Markus J Hofer; Raman Saggu; Gabor C Petzold; Michael T Heneka; Daniel R Getts; Albert Becker; Iain L Campbell; Marcus Müller
Journal:  Mol Neurobiol       Date:  2019-06-02       Impact factor: 5.590

8.  IL-4/IL-13 Heteroreceptor Influences Th17 Cell Conversion and Sensitivity to Regulatory T Cell Suppression To Restrain Experimental Allergic Encephalomyelitis.

Authors:  Subhasis Barik; Jason S Ellis; Jason A Cascio; Mindy M Miller; Tobechukwu K Ukah; Alexis N Cattin-Roy; Habib Zaghouani
Journal:  J Immunol       Date:  2017-08-11       Impact factor: 5.422

Review 9.  Modeling the heterogeneity of multiple sclerosis in animals.

Authors:  Sarah B Simmons; Emily R Pierson; Sarah Y Lee; Joan M Goverman
Journal:  Trends Immunol       Date:  2013-05-21       Impact factor: 16.687

10.  A T-bet gradient controls the fate and function of CCR6-RORγt+ innate lymphoid cells.

Authors:  Christoph S N Klose; Elina A Kiss; Vera Schwierzeck; Karolina Ebert; Thomas Hoyler; Yannick d'Hargues; Nathalie Göppert; Andrew L Croxford; Ari Waisman; Yakup Tanriver; Andreas Diefenbach
Journal:  Nature       Date:  2013-01-16       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.